These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 24876351)

  • 1. Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.
    Michineau S; Franck G; Wagner-Ballon O; Dai J; Allaire E; Gervais M
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1747-55. PubMed ID: 24876351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression.
    Iida Y; Xu B; Xuan H; Glover KJ; Tanaka H; Hu X; Fujimura N; Wang W; Schultz JR; Turner CR; Dalman RL
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):718-26. PubMed ID: 23288157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways.
    Nakao T; Horie T; Baba O; Nishiga M; Nishino T; Izuhara M; Kuwabara Y; Nishi H; Usami S; Nakazeki F; Ide Y; Koyama S; Kimura M; Sowa N; Ohno S; Aoki H; Hasegawa K; Sakamoto K; Minatoya K; Kimura T; Ono K
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2161-2170. PubMed ID: 28882868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization.
    Kaneko H; Anzai T; Morisawa M; Kohno T; Nagai T; Anzai A; Takahashi T; Shimoda M; Sasaki A; Maekawa Y; Yoshimura K; Aoki H; Tsubota K; Yoshikawa T; Okada Y; Ogawa S; Fukuda K
    Atherosclerosis; 2011 Aug; 217(2):350-7. PubMed ID: 21530968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-Bound Thrombomodulin Regulates Macrophage Inflammation in Abdominal Aortic Aneurysm.
    Wang KC; Li YH; Shi GY; Tsai HW; Luo CY; Cheng MH; Ma CY; Hsu YY; Cheng TL; Chang BI; Lai CH; Wu HL
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2412-22. PubMed ID: 26338301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm.
    Tazume H; Miyata K; Tian Z; Endo M; Horiguchi H; Takahashi O; Horio E; Tsukano H; Kadomatsu T; Nakashima Y; Kunitomo R; Kaneko Y; Moriyama S; Sakaguchi H; Okamoto K; Hara M; Yoshinaga T; Yoshimura K; Aoki H; Araki K; Hao H; Kawasuji M; Oike Y
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1400-9. PubMed ID: 22556334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice.
    Zhang J; Chen H; Liu L; Sun J; Shi MA; Sukhova GK; Shi GP
    Cardiovasc Res; 2012 Dec; 96(3):543-51. PubMed ID: 22871590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic Lung Inflammation Aggravates Angiotensin II-Induced Abdominal Aortic Aneurysms in Mice.
    Liu CL; Wang Y; Liao M; Wemmelund H; Ren J; Fernandes C; Zhou Y; Sukhova GK; Lindholt JS; Johnsen SP; Zhang JY; Cheng X; Huang X; Daugherty A; Levy BD; Libby P; Shi GP
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):69-77. PubMed ID: 26543094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation.
    Ding Y; Li X; Zhou M; Cai L; Tang H; Xie T; Shi Z; Fu W
    Vascul Pharmacol; 2021 Feb; 136():106818. PubMed ID: 33227452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation.
    Leeper NJ; Tedesco MM; Kojima Y; Schultz GM; Kundu RK; Ashley EA; Tsao PS; Dalman RL; Quertermous T
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1329-35. PubMed ID: 19304942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.
    Usui F; Shirasuna K; Kimura H; Tatsumi K; Kawashima A; Karasawa T; Yoshimura K; Aoki H; Tsutsui H; Noda T; Sagara J; Taniguchi S; Takahashi M
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):127-36. PubMed ID: 25378412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD95-ligand contributes to abdominal aortic aneurysm progression by modulating inflammation.
    Liu Z; Fitzgerald M; Meisinger T; Batra R; Suh M; Greene H; Penrice AJ; Sun L; Baxter BT; Xiong W
    Cardiovasc Res; 2019 Mar; 115(4):807-818. PubMed ID: 30428004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spermidine Suppresses Development of Experimental Abdominal Aortic Aneurysms.
    Liu S; Huang T; Liu R; Cai H; Pan B; Liao M; Yang P; Wang L; Huang J; Ge Y; Xu B; Wang W
    J Am Heart Assoc; 2020 Apr; 9(8):e014757. PubMed ID: 32308093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
    Spinosa M; Su G; Salmon MD; Lu G; Cullen JM; Fashandi AZ; Hawkins RB; Montgomery W; Meher AK; Conte MS; Sharma AK; Ailawadi G; Upchurch GR
    J Vasc Surg; 2018 Dec; 68(6S):93S-103S. PubMed ID: 30470363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of CaCl
    Ishida Y; Kuninaka Y; Nosaka M; Kimura A; Taruya A; Furuta M; Mukaida N; Kondo T
    Nat Commun; 2020 Nov; 11(1):5994. PubMed ID: 33239616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of catalase in vascular smooth muscle cells prevents the formation of abdominal aortic aneurysms.
    Parastatidis I; Weiss D; Joseph G; Taylor WR
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2389-96. PubMed ID: 23950141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow mesenchymal stem cells stabilize already-formed aortic aneurysms more efficiently than vascular smooth muscle cells in a rat model.
    Schneider F; Saucy F; de Blic R; Dai J; Mohand F; Rouard H; Ricco JB; Becquemin JP; Gervais M; Allaire E
    Eur J Vasc Endovasc Surg; 2013 Jun; 45(6):666-72. PubMed ID: 23598054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of abdominal aortic aneurysm formation by inhibition of prolyl hydroxylase domain protein through attenuation of inflammation and extracellular matrix disruption.
    Watanabe A; Ichiki T; Sankoda C; Takahara Y; Ikeda J; Inoue E; Tokunou T; Kitamoto S; Sunagawa K
    Clin Sci (Lond); 2014 May; 126(9):671-8. PubMed ID: 24256203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease-Associated Abdominal Aortic Aneurysm.
    Wakita D; Kurashima Y; Crother TR; Noval Rivas M; Lee Y; Chen S; Fury W; Bai Y; Wagner S; Li D; Lehman T; Fishbein MC; Hoffman HM; Shah PK; Shimada K; Arditi M
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):886-97. PubMed ID: 26941015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine kinase inhibition protects mice from abdominal aortic aneurysm via epigenetic modulation of VSMC inflammation.
    Xu J; Liu Z; Yang Q; Ma Q; Zhou Y; Cai Y; Zhao D; Zhao G; Lu T; Ouyang K; Hong M; Kim HW; Shi H; Zhang J; Fulton D; Miller C; Malhotra R; Weintraub NL; Huo Y
    Cardiovasc Res; 2024 Sep; 120(10):1202-1217. PubMed ID: 38722818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.